SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-512639"
 

Search: onr:"swepub:oai:DiVA.org:uu-512639" > Operational Challen...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Operational Challenges and Mitigation Measures during the COVID-19 Pandemic-Lessons from DELIVER.

Bhatt, Ankeet S. (author)
Lindholm, Daniel (author)
Nilsson, Ann (author)
show more...
Zaozerska, Natalia (author)
Claggett, Brian L. (author)
Vaduganathan, Muthiah (author)
Kosiborod, Mikhail N. (author)
Lam, Carolyn S. P. (author)
Hernandez, Adrian F. (author)
Martinez, Felipe A. (author)
Inzucchi, Silvio E. (author)
Shah, Sanjiv J. (author)
de Boer, Rudolf A. (author)
Desai, Akshay (author)
Jhund, Pardeep S. (author)
Langkilde, Anna Maria (author)
Petersson, Magnus (author)
McMurray, John J. V. (author)
Solomon, Scott D. (author)
show less...
2023
2023
English.
In: American heart journal. ; 263, s. 133-140
Related links:
https://urn.kb.se/re...
show more...
https://doi.org/10.1...
show less...
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BACKGROUND: Catastrophic disruptions in care delivery threaten the operational efficiency and potentially the validity of clinical research efforts, in particular randomized clinical trials. Most recently, the COVID-19 pandemic affected essentially all aspects of care delivery and clinical research conduct. While consensus statements and clinical guidance documents have detailed potential mitigation measures, few real- world experiences detailing clinical trial adaptations to the COVID-19 pandemic exist, particularly among, large, global registrational cardiovascular trials. METHODS: We outline the operational impact of COVID-19 and resultant mitigation measures in the Dapagliflozin Evaluation to Improve the LIVEs of Patients with Preserved Ejection Fraction Heart Failure (DELIVER) trial, one of the largest and most globally diverse experiences with COVID-19 of any cardiovascular clinical trial to date. Specifically, we address the needed coordination between academic investigators, trial leadership, clinical sites, and the supporting sponsor to ensure the safety of participants and trial staff, to maintain the fidelity of trial operations, and to prospectively adapt statistical analyses plans to evaluate the impact of COVID-19 and the pandemic at large on trial participants. These discussions included key operational issues such as ensuring delivery of study medications, adaptations to study visits, enhanced COVID-19 related endpoint adjudication, and protocol and analytical plan revisions. CONCLUSION: Our findings may have important implications for establishing consensus on prospective contingency planning in future clinical trials. CLINICALTRIAL: gov: NCT03619213. CLINICALTRIAL: GOV: NCT03619213.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

*COVID-19/epidemiology
Humans
Pandemics/prevention & control
Prospective Studies
Randomized Controlled Trials as Topic
Research Design
SARS-CoV-2

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view